Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome
Open accessAbstract
It is not understood how immune inflammation influences the pathogenesis of severe acute respiratory syndrome (SARS). One area of strong controversy is the role of interferon (IFN) responses in the natural history of SARS. The fact that the majority of SARS patients recover after relatively moderate illness suggests that the prevailing notion of deficient type I IFN-mediated immunity, with hypercytokinemia driving a poor clinical course, is oversimplified. We used proteomic and genomic technology to systematically analyze host innate and adaptive immune responses of 40 clinically well-described patients with SARS during discrete phases of illness from the onset of symptoms to discharge or a fatal outcome. A novel signature of high IFN-α, IFN-γ, and IFN-stimulated chemokine levels, plus robust antiviral IFN-stimulated gene (ISG) expression, accompanied early SARS sequelae. As acute illness progressed, SARS patients entered a crisis phase linked to oxygen saturation profiles. The majority of SARS patients resolved IFN responses at crisis and expressed adaptive immune genes. In contrast, patients with poor outcomes showed deviated ISG and immunoglobulin gene expression levels, persistent chemokine levels, and deficient anti-SARS spike antibody production. We contend that unregulated IFN responses during acute-phase SARS may culminate in a malfunction of the switch from innate immunity to adaptive immunity. The potential for the use of the gene signatures we describe in this study to better assess the immunopathology and clinical management of severe viral infections, such as SARS and avian influenza (H5N1), is therefore worth careful examination.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Atypical IFN-mediated immune responses suggest that type I IFN signaling may be important in the pathogenesis of SARS-CoV.
“Atypical IFNmediated immune responses suggest that type I IFN signaling may be important in the pathogenesis of SARS-CoV (21).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [21]
Gene expression signatures for type I and type II IFN responses in the lungs of SARS patients revealed persistent expression of CXCL10, CCL2, IFNAR1, IFNGR1, and CD58.
“Gene expression signatures for type I and type II IFN responses in the lungs of SARS patients revealed persistent expression of CXCL10, CCL2, IFNAR1, IFNGR1, and CD58.”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [21]
Cites
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327 · see citing works
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · see citing works
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · see citing works
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120 · see citing works
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · see citing works
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375 · see citing works
MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126 · see citing works
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858 · see citing works
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270 · see citing works
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217 · see citing works
Lung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076 · see citing works
Ding, Y., He, L., Zhang, Q., Huang, Z., Che, X., Hou, J., Wang, H., Shen, H., Qiu, L., Li, Z., et al. (2004) · The Journal of Pathology · doi:10.1002/path.1560 · Cited by 1,068 · see citing works
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934 · see citing works
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M. A. E., Walker, E. M., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 902 · see citing works
Yang, J., Feng, Y.-Z., Yuan, M. Y., Yuan, S. Y., Fu, H., Wu, B., Sun, G., Yang, G. R., Zhang, X. L., Wang, L., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01861.x · Cited by 793 · see citing works
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679 · see citing works
Lee, N. L. S., Chan, K. C. A., Hui, D. S. C., Ng, E. K. O., Wu, A. K., Chiu, R. W. K., Wong, V. W., Chan, P. K. S., Wong, K. T., Wong, E., et al. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.07.006 · Cited by 636 · see citing works
Interferon signalling network in innate defence
Takaoka, A., & Yanai, H. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00716.x · Cited by 586 · see citing works
Wong, R., Wu, A., To, K.-F., Lee, N., Lam, C., Wong, C., Chan, P. K., Ng, M., Yu, L., Hui, D., et al. (2003) · British medical journal · doi:10.1136/bmj.326.7403.1358 · Cited by 566 · see citing works
Nguyen, K. B., Watford, W. T., Salomon, R., Hofmann, S. R., Pien, G. C., Morinobu, A., Gadina, M., O’Shea, J. J., & Biron, C. A. (2002) · Science · doi:10.1126/science.1074900 · Cited by 495 · see citing works
Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells
Law, H., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, M. J. S., & Lau, Y. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 467 · see citing works
Cheung, C. Y., Poon, L. L. M., Ng, I. H. Y., Luk, W., Sia, S. F., Wu, M. H. S., Chan, K., Yuen, K., Gordon, S., Guan, Y., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7819-7826.2005 · Cited by 461 · see citing works
Induction and Regulation of IFNs During Viral Infections
Malmgaard, L. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/1079990041689665 · Cited by 455 · see citing works
Lew, T. W. K. (2003) · JAMA · doi:10.1001/jama.290.3.374 · Cited by 423 · see citing works
Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon
Cervantes‐Barragán, L., Züst, R., Weber, F., Spiegel, M., Lang, K. S., Akira, S., Thiel, V., & Ludewig, B. (2006) · Blood · doi:10.1182/blood-2006-05-023770 · Cited by 397 · see citing works
Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong
Choi, K., Chau, T., Tsang, O. T. Y., Tso, E. Y. K., Chiu, M. C., Tong, W., Lee, P. O., Ng, T. K., Ng, W. F., Lee, K. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-9-200311040-00005 · Cited by 392 · see citing works
Pulmonary pathology of severe acute respiratory syndrome in Toronto
Hwang, D. M., Chamberlain, D. W., Poutanen, S. M., Low, D. E., Asa, S. L., & Butany, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800247 · Cited by 332 · see citing works
Critically Ill Patients With Severe Acute Respiratory Syndrome
Fowler, R. (2003) · JAMA · doi:10.1001/jama.290.3.367 · Cited by 315 · see citing works
Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome
Reghunathan, R., Jayapal, M., Hsu, L. Y., Chng, H. H., Tai, D. Y. H., Leung, B. P. L., & Melendez, A. J. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-2 · Cited by 295 · see citing works
Tang, N. L. S., Chan, P. K. S., Wong, C.-K., To, K., Wu, A. K. L., Sung, Y.-M., Hui, D. S. C., Sung, J. J. �., & Lam, C. W. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.054460 · Cited by 231 · see citing works
Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates
Tsui, P. T., Ml, K., Yuen, H., & Lai, S. T. (2003) · Emerging infectious diseases · doi:10.3201/eid0909.030362 · Cited by 220 · see citing works
Review: IFN- α / β Receptor Interactions to Biologic Outcomes: Understanding the Circuitry
Brierley, M. M., & Fish, E. N. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760274845 · Cited by 190 · see citing works
Stats: Multifaceted Regulators of Transcription
Brierley, M. M., & Fish, E. N. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.733 · Cited by 190 · see citing works
Pathogenesis of severe acute respiratory syndrome
Lau, Y., & Peiris, M. J. S. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.009 · Cited by 168 · see citing works
Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus
Farcas, G. A., Poutanen, S. M., Mazzulli, T., Willey, B. M., BUTANY, J. W., Asa, S. L., Faure, P., Akhavan, P., Low, D. E., & Kain, K. C. (2004) · The Journal of Infectious Diseases · doi:10.1086/426870 · Cited by 168 · see citing works
Self-citationNie, Y., Wang, G., Shi, X., Zhang, H., Yan, Q., Zhong-ping, H., Wei, W., Lian, G., Yin, X., Du, L., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423286 · Cited by 146 · see citing works
Kumar, D., Tellier, R., Draker, R., Levy, G. A., & Humar, A. (2003) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2003.00197.x · Cited by 138 · see citing works
Self-citationType I interferons and the innate immune response--more than just antiviral cytokines.
Smith, P., Lombardi, G., & Foster, G. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.11.008 · Cited by 133 · see citing works
Host innate defenses in the lung: the role of cytokines
Strieter, R. M., Belperio, J. A., & Keane, M. P. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200306000-00002 · Cited by 126 · see citing works
Hamano, E., Hijikata, M., Itoyama, S., Quy, T., Phi, N. C., Long, H. T., Hà, L. D., Ban, V. V., Matsushita, I., Yanai, H., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.101 · Cited by 114 · see citing works
He, J., Feng, D., de Vlas, S. J., Wang, H., Fontanet, A. L., Zhang, P., Plancoulaine, S., Tang, F., Zhan, L., Yang, H., et al. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-106 · Cited by 101 · see citing works
Chen, C., Lee, C., Liu, C.-Y., Wang, J.-H., Wang, L.-M., & Perng, R.-P. (2005) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(09)70124-8 · Cited by 101 · see citing works
Clinical course and management of SARS in health care workers in Toronto: a case series.
Avendaño, M. A., Derkach, P., & Swan, S. (2003) · Europe PMC (PubMed Central) · Cited by 99 · see citing works
Ziegler, T. T., Matikainen, S., Rönkkö, E., Österlund, P., Sillanpää, M., Sirén, J., Fagerlund, R., Immonen, M., Melén, K., & Julkunen, I. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13800-13805.2005 · Cited by 78 · see citing works
Prognostic Factors for Severe Acute Respiratory Syndrome: A Clinical Analysis of 165 Cases
Zou, Z., Yang, Y., Chen, J.-M., Xin, S., Zhang, W., Zhou, X., Mao, Y., Hu, L., Liu, D., Chang, B., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380973 · Cited by 60 · see citing works
How the SARS coronavirus causes disease: host or organism?
Lo, A. W. I., Tang, N. L. S., & To, K. (2005) · The Journal of Pathology · doi:10.1002/path.1897 · Cited by 55 · see citing works
Gene expression profiles in peripheral blood mononuclear cells of SARS patients
Yu, S.-Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i32.5037 · Cited by 49 · see citing works
Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication
Castilletti, C., Bordi, L., Lalle, E., Rozera, G., Poccia, F., Agrati, C., Abbate, I., & Capobianchi, M. R. (2005) · Virology · doi:10.1016/j.virol.2005.07.015 · Cited by 41 · see citing works
An approach for clustering gene expression data with error information
Tjaden, B. C. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-17 · Cited by 41 · see citing works
Lee, Y.-S., Chen, C., Chao, A., Chen, E.-S., Wei, M., Chen, L.-K., Yang, K. D., Lin, M.-C., Wang, Y.-H., Liu, J.-W., et al. (2005) · BMC Genomics · doi:10.1186/1471-2164-6-132 · Cited by 39 · see citing works
Han, T., Melvin, C. D., Shi, L. M., Branham, W. S., Moland, C. L., Pine, P. S., Thompson, K. L., & Fuscoe, J. C. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-s2-s17 · Cited by 37 · see citing works
APOPTOSIS PREVENTION AS A MECHANISM OF IMMUNE EVASION
Aubert, M., & Jerome, K. R. (2003) · International Reviews of Immunology · doi:10.1080/08830180305213 · Cited by 35 · see citing works
Effect of Hepatitis C Virus Core Protein on the Molecular Profiling of Human B Lymphocytes
Wu, C.-G., Budhu, A., Chen, S., Zhou, X., Popescu, N. C., Valerie, K. C., & Wang, X. W. (2006) · Molecular Medicine · doi:10.2119/2006-00020.wu · Cited by 32 · see citing works
Dutta, N., Gupta, A., Mazumder, D. G., & Banerjee, S. (2006) · Cancer · doi:10.1002/cncr.21784 · Cited by 25 · see citing works
Representative appressorium stage cDNA library of Magnaporthe grisea
Lu, J., Liu, T., Yu, X., & Lin, F. (2005) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2005.b0132 · Cited by 22 · see citing works
Clinical Prognostic Rules for Severe Acute Respiratory Syndrome in Low- and High-Resource Settings
Cowling, B. J., Muller, M. P., Wong, I. O. L., Ho, L., Lo, S., Tsang, T., Lam, T. H., Louie, M., & Leung, G. M. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.14.1505 · Cited by 17 · see citing works
Self-citationImpaired Regulation of HLA-DR Expression in Human Immunodeficiency Virus-Infected Monocytes
Shao, L., & Sperber, K. E. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.4.739-746.2002 · Cited by 14 · see citing works
ARDS in SARS: cytokine mediators and treatment implications
Salto‐Tellez, M., Tan, E. L. C., & Lim, B. (2004) · Cytokine · doi:10.1016/j.cyto.2004.09.002 · Cited by 12 · see citing works
Mandavilli, A. (2006) · Nature · doi:10.1038/439382a · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477 · see citing works
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510 · see citing works
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · see citing works
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074 · see citing works
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · see citing works
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S. M., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,766 · see citing works
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493 · see citing works
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works
Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008) · Journal of Virology · doi:10.1128/jvi.00737-08 · Cited by 1,293 · see citing works
Middle East respiratory syndrome
Zumla, A. I., Hui, D. S. C., & Perlman, S. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60454-8 · Cited by 1,280 · see citing works
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Tang, Y., Liu, J., Zhang, D., Xu, Z., Ji, J., & Wen, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01708 · Cited by 1,094 · see citing works
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhou, Z. L., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.017 · Cited by 963 · see citing works
Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909 · see citing works
Weiss, S. R., & Leibowitz, J. L. (2011) · Advances in virus research · doi:10.1016/b978-0-12-385885-6.00009-2 · Cited by 899 · see citing works
SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M., & BUTANY, J. W. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02153.x · Cited by 896 · see citing works
Self-citationChan, J. F., Lau, S. K. P., To, K. K., Cheng, V. C., Woo, P. C. Y., & Yuen, K. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 880 · see citing works
The immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N. P., & Haynes, B. F. (2009) · Nature reviews. Immunology · doi:10.1038/nri2674 · Cited by 871 · see citing works
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192 · see citing works
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · see citing works
Bradley, B. T., Maioli, H., Johnston, R., Chaudhry, I., Fink, S. L., Xu, H., Najafian, B., Deutsch, G. H., Lacy, J. M., Williams, T., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31305-2 · Cited by 814 · see citing works
Stacey, A., Norris, P. J., Li, Q., Haygreen, E. A., Taylor, E., Heitman, J. W., Lebedeva, M., deCamp, A. C., Li, D., Grove, D. I., et al. (2009) · Journal of Virology · doi:10.1128/jvi.01844-08 · Cited by 749 · see citing works
A decade after SARS: strategies for controlling emerging coronaviruses
Graham, R. L., Donaldson, E., & Baric, R. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3143 · Cited by 676 · see citing works
Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 618 · see citing works
Nikolich-Zugich, J., Knox, K. S., Rios, C. T., Natt, B., Bhattacharya, D., & Fain, M. J. (2020) · GeroScience · doi:10.1007/s11357-020-00186-0 · Cited by 577 · see citing works
The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
Domizio, J. D., Gulen, M. F., Saidoune, F., Thacker, V. V., Yatim, A., Sharma, K., Nass, T., Guenova, E., Schaller, M., Conrad, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04421-w · Cited by 538 · see citing works
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Miorin, L., Kehrer, T., Sánchez-Aparicio, M. T., Zhang, K., Cohen, P. D., Patel, R. S., Čupić, A., Makio, T., Mei, M., Moreno, E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016650117 · Cited by 517 · see citing works
Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477 · see citing works
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
Major, J., Crotta, S., Llorian, M., McCabe, T. M., Gad, H. H., Priestnall, S. L., Hartmann, R., & Wack, A. (2020) · Science · doi:10.1126/science.abc2061 · Cited by 488 · see citing works
T Cell Responses to Whole SARS Coronavirus in Humans
Li, C. K., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 499 · see citing works
Myocardial injury and COVID-19: Possible mechanisms
Babapoor-Farrokhran, S., Gill, D., Walker, J., Rasekhi, R. T., Bozorgnia, B., & Amanullah, A. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117723 · Cited by 483 · see citing works
Middle East respiratory syndrome
Memish, Z. A., Perlman, S. M., Kerkhove, M. D. V., & Zumla, A. I. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33221-0 · Cited by 481 · see citing works
Totura, A. L., Whitmore, A. C., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S. (2015) · mBio · doi:10.1128/mbio.00638-15 · Cited by 479 · see citing works
Dysregulation of type I interferon responses in COVID-19
Acharya, D., Liu, G., & Gack, M. U. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0346-x · Cited by 454 · see citing works
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Israelow, B., Song, E., Mao, T., Lu, P., Meir, A., Liu, F., Alfajaro, M. M., Wei, J., Dong, H., Homer, R. J., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201241 · Cited by 415 · see citing works
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Totura, A. L., & Baric, R. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.04.004 · Cited by 416 · see citing works
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Broggi, A., Ghosh, S., Sposito, B., Spreafico, R., Balzarini, F., Cascio, A. L., Clementi, N., Santis, M. D., Mancini, N., Granucci, F., et al. (2020) · Science · doi:10.1126/science.abc3545 · Cited by 398 · see citing works
Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2009) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 400 · see citing works
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Oladunni, F. S., Park, J.-G., Pino, P., Gonzalez, O., Akhter, A., Allué-Guardia, A., Olmo-Fontánez, A. M., Gautam, S., Garcia-Vilanova, A., Ye, C.-J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19891-7 · Cited by 394 · see citing works
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
Liu, W. J., Zhao, M. J., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 397 · see citing works
DeDiego, M. L., Nieto-Torres, J. L., Regla-Nava, J. Á., Jiménez-Guardeño, J. M., Fernández‐Delgado, R., Fett, C., Castaño-Rodríguez, C., Perlman, S. M., & Enjuanes, L. (2013) · Journal of Virology · doi:10.1128/jvi.02576-13 · Cited by 395 · see citing works
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Bermejo-Martín, J. F., de Lejarazu, R. O., Pumarola, T., Rello, J., Almansa, R., Ramírez, P., Martín‐Loeches, I., Varillas‐Delgado, D., Gallegos, M. C., Arbeloa, C. S., et al. (2009) · Critical Care · doi:10.1186/cc8208 · Cited by 373 · see citing works
Self-citationAboudounya, M. M., & Heads, R. J. (2021) · Mediators of Inflammation · doi:10.1155/2021/8874339 · Cited by 351 · see citing works
Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340 · see citing works
Pathophysiology of COVID-19: Why Children Fare Better than Adults?
Dhochak, N., Singhal, T., Kabra, S. K., & Lodha, R. (2020) · The Indian Journal of Pediatrics · doi:10.1007/s12098-020-03322-y · Cited by 344 · see citing works
Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates
Smits, S. L., de Lang, A., van den Brand, J. M. A., Leijten, L. M. E., van IJcken, W. F. J., Eijkemans, M. J. C., van Amerongen, G., Kuiken, T., Andeweg, A. C., Osterhaus, A. D. M. E., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000756 · Cited by 331 · see citing works
Lymphopenia in COVID‐19: Therapeutic opportunities
Fathi, N., & Rezaei, N. (2020) · Cell Biology International · doi:10.1002/cbin.11403 · Cited by 324 · see citing works
Molecular pathology of emerging coronavirus infections
Gralinski, L. E., & Baric, R. S. (2014) · The Journal of Pathology · doi:10.1002/path.4454 · Cited by 315 · see citing works
Lessons for COVID-19 immunity from other coronavirus infections
Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317 · see citing works
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
Luo, W., Li, Y., Jiang, L., Chen, Q., Wang, T., & Ye, D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.007 · Cited by 292 · see citing works
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Lowery, S. A., Sariol, A., & Perlman, S. (2021) · Cell Host and Microbe · doi:10.1016/j.chom.2021.05.004 · Cited by 268 · see citing works
Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients
Stebbing, J., Krishnan, V., de Bono, S., Ottaviani, S., Casalini, G., Richardson, P. J., Monteil, V., Lauschke, V. M., Mirazimi, A., Youhanna, S. C., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012697 · Cited by 291 · see citing works
Two distinct immunopathological profiles in autopsy lungs of COVID-19
Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M., Frank, A., Zsikla, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18854-2 · Cited by 246 · see citing works
Bermejo-Martín, J. F., González‐Rivera, M., Almansa, R., Micheloud, D., Tedim, A. P., Domínguez‐Gil, M., Resino, S., Martín-Fernández, M., Ryan, P., Pérez‐García, F., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03398-0 · Cited by 264 · see citing works
Self-citationDistinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, É., Titécat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 249 · see citing works
Chemokines and chemokine receptors during COVID-19 infection
Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 246 · see citing works
Dosch, S. F., Mahajan, S. D., & Collins, A. R. (2009) · Virus Research · doi:10.1016/j.virusres.2009.01.005 · Cited by 228 · see citing works
Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections
Nelemans, T., & Kikkert, M. (2019) · Viruses · doi:10.3390/v11100961 · Cited by 224 · see citing works
Rokni, M., Ghasemi, V., & Tavakoli, Z. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2107 · Cited by 222 · see citing works
DeDiego, M. L., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Álvarez, E. A., Oliveros, J. C., Zhao, J., Fett, C., Perlman, S. M., & Enjuanes, L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002315 · Cited by 213 · see citing works
Martín‐Loeches, I., Lisboa, T. C., Rhodes, A., Moreno, R. P., Silva, E., Sprung, C. L., Chiche, J., Barahona, D., Villabon, M., Balasini, C., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-2078-z · Cited by 211 · see citing works
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Sheahan, T. P., Morrison, T. E., Funkhouser, W., Uematsu, S., Akira, S., Baric, R. S., & Heise, M. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000240 · Cited by 207 · see citing works
Mubarak, A., Alturaiki, W., & Hemida, M. G. (2019) · Journal of Immunology Research · doi:10.1155/2019/6491738 · Cited by 199 · see citing works
Jiang, Y., Zhao, G., Song, N., Li, P., Chen, Y., Guo, Y., Li, J., Du, L., Jiang, S., Guo, R., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0063-8 · Cited by 195 · see citing works
Wong, L.-Y. R., & Perlman, S. M. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00656-2 · Cited by 196 · see citing works
Thieme, C. J., Anft, M., Paniskaki, K., Blazquez-Navarro, A., Doevelaar, A., Seibert, F. S., Hoelzer, B., Konik, M. J., Berger, M. M., Brenner, T., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100092 · Cited by 184 · see citing works
Natural Killer Cells Promote Early CD8 T Cell Responses against Cytomegalovirus
Robbins, S. H., Bessou, G., Cornillon, A., Zucchini, N., Rupp, B., Ruzsics, Z., Sacher, T., Tomasello, E., Vivier, É., Koszinowski, U. H., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030123 · Cited by 187 · see citing works
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice
Li, K., Wohlford-Lenane, C., Channappanavar, R., Park, J.-E., Earnest, J. T., Bair, T., Bates, A. M., Brogden, K. A., Flaherty, H. A., Gallagher, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619109114 · Cited by 183 · see citing works
Coronavirus virulence genes with main focus on SARS-CoV envelope gene
DeDiego, M. L., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Regla-Nava, J. Á., Castaño-Rodríguez, C., Fernández‐Delgado, R., Usera, F., & Enjuanes, L. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.024 · Cited by 174 · see citing works
Gene Expression Analysis of Host Innate Immune Responses during Lethal H5N1 Infection in Ferrets
Cameron, C., Cameron, M. J., Bermejo-Martín, J. F., Ran, L., Xu, L., Turner, P. V., Ran, R., Danesh, A., Yuan, F., Chan, P.-K., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00691-08 · Cited by 176 · see citing works
Self-citationKelvin, A. A., Banner, D., Silvi, G., Moro, M. L., Spataro, N., Gaibani, P., Cavrini, F., Pierro, A. M., Rossini, G., Cameron, M. J., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001279 · Cited by 175 · see citing works
Self-citationRockx, B., Baas, T., Zornetzer, G. A., Haagmans, B. L., Sheahan, T. P., Frieman, M. B., Dyer, M. D., Teal, T. H., Proll, S. C., van den Brand, J. M. A., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00127-09 · Cited by 175 · see citing works
Host adaptive immunity deficiency in severe pandemic influenza
Bermejo-Martín, J. F., Martín‐Loeches, I., Rello, J., Antón, A., Almansa, R., Xu, L., López–Campos, G., Pumarola, T., Ran, L., Ramírez, P., et al. (2010) · Critical Care · doi:10.1186/cc9259 · Cited by 174 · see citing works
Self-citationvan den Brand, J. M. A., Haagmans, B. L., van Riel, D. A. J., Osterhaus, A. D. M. E., & Kuiken, T. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.01.004 · Cited by 158 · see citing works
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000849 · Cited by 158 · see citing works
Is asthma protective against COVID‐19?
Carli, G., Cecchi, L., Stebbing, J., Parronchi, P., & Farsi, A. (2020) · Allergy · doi:10.1111/all.14426 · Cited by 155 · see citing works
Immune responses during COVID-19 infection
Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 162 · see citing works
Interferon and cytokine responses to SARS-coronavirus infection
Thiel, V., & Weber, F. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.001 · Cited by 149 · see citing works
Pathogenesis of Middle East respiratory syndrome coronavirus
van den Brand, J. M. A., Smits, S. L., & Haagmans, B. L. (2014) · The Journal of Pathology · doi:10.1002/path.4458 · Cited by 152 · see citing works
Zhao, J., Zhao, J., van Rooijen, N., & Perlman, S. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000636 · Cited by 151 · see citing works
Regla-Nava, J. Á., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Fernández‐Delgado, R., Fett, C., Castaño-Rodríguez, C., Perlman, S. M., Enjuanes, L., & DeDiego, M. L. (2015) · Journal of Virology · doi:10.1128/jvi.03566-14 · Cited by 152 · see citing works
Innate immune modulation by RNA viruses: emerging insights from functional genomics
Katze, M. G., Fornek, J. L., Palermo, R. E., Walters, K., & Korth, M. J. (2008) · Nature reviews. Immunology · doi:10.1038/nri2377 · Cited by 148 · see citing works
Intranasal Treatment with Poly(I·C) Protects Aged Mice from Lethal Respiratory Virus Infections
Zhao, J., Wohlford-Lenane, C., Zhao, J., Fleming, E., Lane, T. E., McCray, P. B., & Perlman, S. M. (2012) · Journal of Virology · doi:10.1128/jvi.01410-12 · Cited by 140 · see citing works
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies
Baik, A. H., Oluwole, O. O., Johnson, D. B., Shah, N., Salem, J.-E., Tsai, K. K., & Moslehi, J. J. (2021) · Circulation Research · doi:10.1161/circresaha.120.315894 · Cited by 138 · see citing works
Netland, J., DeDiego, M. L., Zhao, J., Fett, C., Álvarez, E. A., Nieto-Torres, J. L., Enjuanes, L., & Perlman, S. M. (2010) · Virology · doi:10.1016/j.virol.2010.01.004 · Cited by 134 · see citing works
Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses
Bordt, E. A., Shook, L. L., Atyeo, C. G., Pullen, K. M., Guzman, R. M. D., Meinsohn, M.-C., Chauvin, M. Y., Fischinger, S., Yockey, L. J., James, K. E., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi7428 · Cited by 134 · see citing works
Paračková, Z., Zentsová, I., Bloomfield, M., Vrabcová, P., Smetanová, J., Klocperk, A., Mesežnikov, G., Méndez, L. F. C., Vymazal, T., & Šedivá, A. (2020) · Cells · doi:10.3390/cells9102206 · Cited by 129 · see citing works
Mohapatra, R. K., Pintilie, L., Kandi, V., Sarangi, A. K., Das, D., Sahu, R., & Perekhoda, L. O. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13761 · Cited by 128 · see citing works
T cell immunobiology and cytokine storm of COVID‐19
Luo, X.-H., Zhu, Y., Mao, J., & Du, R. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12989 · Cited by 106 · see citing works
Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System
Lima, M., Siokas, V., Aloizou, A., Liampas, I., Mentis, A. A., Tsouris, Z., Papadimitriou, A., Mitsias, P. D., Tsatsakis, A. M., Bogdanos, D. P., et al. (2020) · Current Treatment Options in Neurology · doi:10.1007/s11940-020-00647-z · Cited by 126 · see citing works
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
Ceribelli, A., Motta, F., Santis, M. D., Ansari, A. A., Ridgway, W. M., Gershwin, M. E., & Selmi, C. F. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102442 · Cited by 125 · see citing works
Scheuplein, V., Seifried, J., Malczyk, A. H., Miller, L., Höcker, L., Vergara‐Alert, J., Dolnik, O., Zielecki, F., Becker, B., Spreitzer, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.03607-14 · Cited by 123 · see citing works
Transcriptomic correlates of organ failure extent in sepsis
Almansa, R., Heredia‐Rodríguez, M., Gómez‐Sánchez, E., Andaluz‐Ojeda, D., Iglesias, V., Rico, L., Ortega, A., Gómez‐Pesquera, E., Liu, P., Aragón, M. F., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.12.010 · Cited by 122 · see citing works
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
Bermejo-Martín, J. F., Almansa, R., Menéndez, R., Méndez, R., Kelvin, D. J., & Torres, A. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.029 · Cited by 120 · see citing works
Self-citationMuñoz, F. M., Cramer, J. P., Dekker, C. L., Dudley, M. Z., Graham, B. S., Gurwith, M., LAW, B. J., Perlman, S. M., Polack, F. P., Spergel, J. M., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.01.055 · Cited by 115 · see citing works
Approaches and Challenges in SARS-CoV-2 Vaccine Development
Dagotto, G., Yu, J., & Barouch, D. H. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.08.002 · Cited by 103 · see citing works
Network-based analysis of comorbidities risk during an infection: SARS and HIV case studies
Moni, M. A., & Lió, P. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-333 · Cited by 106 · see citing works
Rosa, B. A., Ahmed, M., Singh, D. K., Choreño-Parra, J. A., Cole, J., Jiménez-Álvarez, L. A., Rodríguez-Reyna, T. S., Singh, B., Gonzalez, O., Carrion, R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01829-4 · Cited by 106 · see citing works
Reverse Genetics of SARS-Related Coronavirus Using Vaccinia Virus-Based Recombination
van den Worm, S. H. E., Eriksson, K., Zevenhoven-Dobbe, J. C., Weber, F., Züst, R., Kuri, T., Dijkman, R., Chang, G., Siddell, S. G., Snijder, E. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032857 · Cited by 106 · see citing works
Molecular Biology of the SARS-Coronavirus
Lal, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-642-03683-5 · Cited by 102 · see citing works
- Authors
- Cameron, M. J., Ran, L., Xu, L., Danesh, A., Bermejo-Martin, J. F., Cameron, C. M., Muller, M. P., Gold, W. L., Richardson, S. E., Poutanen, S. M., Willey, B. M., DeVries, M. E., Fang, Y., Seneviratne, C., Bosinger, S. E., Persad, D., Wilkinson, P., Greller, L. D., Somogyi, R., Humar, A., Keshavjee, S., Louie, M., Loeb, M. B., Brunton, J., McGeer, A. J., the Canadian SARS Research Network, & Kelvin, D. J.
- Affiliations
- University Health Network (CA)
- University of Valladolid, Valladolid, Spain
- Mount Sinai Hospital (CA)
- University of Toronto (CA)
- University Health Network, Toronto, Ontario, Canada
- Centre Hospitalier de l’Université de Montréal (CA)
- Biosystemix, Sydenham, Ontario, Canada
- Provincial Laboratory of Public Health (CA)
- McMaster University (CA)
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-08-15
- Volume
- 81
- Issue
- 16
- Pages
- 8692-8706
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC1951379
- OpenAlex
- W2049902839
- Cited by
- 386
- References
- 59
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 31 · 2021: 71 · 2020: 121 · 2019: 5 · 2018: 1 · 2017: 8 · 2016: 7 · 2015: 10 · 2014: 11 · 2013: 10 · 2012: 10
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Genome Canada
- Ontario Genomics
- Ontario Genomics Institute
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, interferon, type I interferon, interferon-stimulated genes, interferon-alpha, interferon-gamma, chemokines, innate immunity, adaptive immunity, immunopathology, SARS-CoV, spike antibodies, immunoglobulin genes, gene expression signatures, cytokine storm, H5N1 avian influenza, viral pathogenesis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antibodies, Viral, Antibody Formation, Female, Humans, Immunity, Innate, Interferons, Male, Middle Aged, Gene Expression, Cytokines, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genomics, Proteomics, Severe Acute Respiratory Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
